30 October 2026 ASX: NX1 QUARTERLY ACTIVITIES, CASHFLOW REPORT AND OPERATIONS UPDATE 30 October 2026 Quarter ended 30 September 2026 Melbourne, Australia – Nexalis Therapeutics Ltd (ASX: NX1), (‘Nexalis’, ‘NX1’ or ‘the Company’), is pleased to provide its quarterly activities report...